Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| agilon health, inc.AGL · Entity 4698 | Chief Markets Officer | April 14, 2026 | April 17, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
agilon health, inc.
Report date April 14, 2026 · Filed April 17, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 123,421 |
Reported balance
After 2026-04-14 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-04-14 · Tax withholding · Disposed 104 · Balance 123,421 F1: Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the restricted stock units and does not represent a sale. |
| Common StockSEC Table I · non-derivative | Direct | 122,850 |
Reported balance
After 2026-04-15 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2026-04-15 · Tax withholding · Disposed 571 · Balance 122,850 F1: Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the restricted stock units and does not represent a sale. F2: Includes restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the restricted stock units and does not represent a sale.
F2: Includes restricted stock units.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 16, 2022 Filed Nov 18, 2022 21:50 UTC | agilon health, inc. AGL · Entity 4698 | Exercise / conversionOptions (Right to buy) · Derivative | 18,750 | $0.00 Strike: $3.00 | $0.00 |
DisclosureSEC source: 0001209191-22-057871 · doc4.xml · derivative · entry 5 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,101 Underlying: Common Stock · 18,750 shares Expires 2026-12-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options were granted on December 30, 2016 and vested on September 14, 2021. Read SEC document |
| November 16, 2022 Filed Nov 18, 2022 21:50 UTC | agilon health, inc. AGL · Entity 4698 | SaleCommon Stock | 18,750 | $18.29 | $343,008.75 |
DisclosureSEC source: 0001209191-22-057871 · doc4.xml · nonDerivative · entry 2 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,625 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $17.91 to $18.77, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| November 16, 2022 Filed Nov 18, 2022 21:50 UTC | agilon health, inc. AGL · Entity 4698 | Exercise / conversionCommon Stock | 18,750 | $3.00 | $56,250.00 |
DisclosureSEC source: 0001209191-22-057871 · doc4.xml · nonDerivative · entry 1 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,375 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| October 20, 2022 Filed Oct 22, 2022 00:52 UTC Amendment | agilon health, inc. AGL · Entity 4698 | SaleCommon Stock | 1,500 | $20.66 | $30,991.05 |
DisclosureSEC source: 0001209191-22-054346 · doc4a.xml · nonDerivative · entry 4 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,625 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $20.64 to $20.71, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F3 · balance_after: Includes restricted stock units. F4 · balance_after: The total was decreased by 1,507 shares as reported in the Form 4 Amendment filed on September 29, 2022. Read SEC document |
| October 20, 2022 Filed Oct 22, 2022 00:52 UTC Amendment | agilon health, inc. AGL · Entity 4698 | SaleCommon Stock | 28,048 | $20.35 | $570,844.12 |
DisclosureSEC source: 0001209191-22-054346 · doc4a.xml · nonDerivative · entry 3 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,125 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $19.64 to $20.63, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F3 · balance_after: Includes restricted stock units. F4 · balance_after: The total was decreased by 1,507 shares as reported in the Form 4 Amendment filed on September 29, 2022. Read SEC document |
| October 20, 2022 Filed Oct 21, 2022 20:09 UTC | agilon health, inc. AGL · Entity 4698 | Exercise / conversionOptions (Right to buy) · Derivative | 29,548 | $0.00 Strike: $3.00 | $0.00 |
DisclosureSEC source: 0001209191-22-054260 · doc4.xml · derivative · entry 8 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,851 Underlying: Common Stock · 29,548 shares Expires 2026-12-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: These options were granted on December 30, 2016 and vested on September 14, 2021. Read SEC document |
| October 20, 2022 Filed Oct 21, 2022 20:09 UTC | agilon health, inc. AGL · Entity 4698 | SaleCommon Stock | 1,500 | $20.66 | $30,991.05 |
DisclosureSEC source: 0001209191-22-054260 · doc4.xml · nonDerivative · entry 6 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,625 F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $20.64 to $20.71, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. F2 · balance_after: The total was decreased by 1,507 shares as reported in the Form 4 Amendment filed on September 29, 2022. Read SEC document |
| October 20, 2022 Filed Oct 21, 2022 20:09 UTC | agilon health, inc. AGL · Entity 4698 | SaleCommon Stock | 28,048 | $20.35 | $570,844.12 |
DisclosureSEC source: 0001209191-22-054260 · doc4.xml · nonDerivative · entry 5 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,125 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $19.64 to $20.63, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. F2 · balance_after: The total was decreased by 1,507 shares as reported in the Form 4 Amendment filed on September 29, 2022. Read SEC document |
| October 20, 2022 Filed Oct 21, 2022 20:09 UTC | agilon health, inc. AGL · Entity 4698 | Exercise / conversionCommon Stock | 29,548 | $3.00 | $88,644.00 |
DisclosureSEC source: 0001209191-22-054260 · doc4.xml · nonDerivative · entry 4 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,173 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. F2 · balance_after: The total was decreased by 1,507 shares as reported in the Form 4 Amendment filed on September 29, 2022. Read SEC document |
| October 19, 2022 Filed Oct 22, 2022 00:52 UTC Amendment | agilon health, inc. AGL · Entity 4698 | SaleCommon Stock | 900 | $20.62 | $18,555.48 |
DisclosureSEC source: 0001209191-22-054346 · doc4a.xml · nonDerivative · entry 2 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,625 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $20.52 to $20.75, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F3 · balance_after: Includes restricted stock units. F4 · balance_after: The total was decreased by 1,507 shares as reported in the Form 4 Amendment filed on September 29, 2022. Read SEC document |
| October 19, 2022 Filed Oct 22, 2022 00:52 UTC Amendment | agilon health, inc. AGL · Entity 4698 | SaleCommon Stock | 19,552 | $19.84 | $387,917.55 |
DisclosureSEC source: 0001209191-22-054346 · doc4a.xml · nonDerivative · entry 1 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,525 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $19.52 to $20.36, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F3 · balance_after: Includes restricted stock units. F4 · balance_after: The total was decreased by 1,507 shares as reported in the Form 4 Amendment filed on September 29, 2022. Read SEC document |
| October 19, 2022 Filed Oct 21, 2022 20:09 UTC | agilon health, inc. AGL · Entity 4698 | Exercise / conversionOptions (Right to buy) · Derivative | 20,452 | $0.00 Strike: $3.00 | $0.00 |
DisclosureSEC source: 0001209191-22-054260 · doc4.xml · derivative · entry 7 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 181,399 Underlying: Common Stock · 20,452 shares Expires 2026-12-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: These options were granted on December 30, 2016 and vested on September 14, 2021. Read SEC document |
| October 19, 2022 Filed Oct 21, 2022 20:09 UTC | agilon health, inc. AGL · Entity 4698 | SaleCommon Stock | 900 | $20.62 | $18,555.48 |
DisclosureSEC source: 0001209191-22-054260 · doc4.xml · nonDerivative · entry 3 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,625 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $20.52 to $20.75, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. F2 · balance_after: The total was decreased by 1,507 shares as reported in the Form 4 Amendment filed on September 29, 2022. Read SEC document |
| October 19, 2022 Filed Oct 21, 2022 20:09 UTC | agilon health, inc. AGL · Entity 4698 | SaleCommon Stock | 19,552 | $19.84 | $387,917.55 |
DisclosureSEC source: 0001209191-22-054260 · doc4.xml · nonDerivative · entry 2 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,525 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $19.52 to $20.36, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. F2 · balance_after: The total was decreased by 1,507 shares as reported in the Form 4 Amendment filed on September 29, 2022. Read SEC document |
| October 19, 2022 Filed Oct 21, 2022 20:09 UTC | agilon health, inc. AGL · Entity 4698 | Exercise / conversionCommon Stock | 20,452 | $3.00 | $61,356.00 |
DisclosureSEC source: 0001209191-22-054260 · doc4.xml · nonDerivative · entry 1 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,077 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. F2 · balance_after: The total was decreased by 1,507 shares as reported in the Form 4 Amendment filed on September 29, 2022. Read SEC document |
| July 21, 2022 Filed Jul 22, 2022 20:07 UTC | agilon health, inc. AGL · Entity 4698 | Exercise / conversionOptions (Rights to Buy) · Derivative | 49,676 | $0.00 Strike: $1.00 | $0.00 |
DisclosureSEC source: 0001209191-22-042987 · doc4.xml · derivative · entry 6 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 327,306 Underlying: Common Stock · 49,676 shares Expires 2026-12-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: These options were granted on December 30, 2016, and became fully vested as of January 12, 2021. Read SEC document |
| July 21, 2022 Filed Jul 22, 2022 20:07 UTC | agilon health, inc. AGL · Entity 4698 | SaleCommon Stock | 10,948 | $28.04 | $307,011.48 |
DisclosureSEC source: 0001209191-22-042987 · doc4.xml · nonDerivative · entry 5 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,132 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $27.92 to $28.36, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F3 · balance_after: Includes restricted stock units. Read SEC document |
| July 21, 2022 Filed Jul 22, 2022 20:07 UTC | agilon health, inc. AGL · Entity 4698 | SaleCommon Stock | 39,052 | $27.63 | $1,078,838.84 |
DisclosureSEC source: 0001209191-22-042987 · doc4.xml · nonDerivative · entry 4 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,080 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $26.92 to $27.91, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F3 · balance_after: Includes restricted stock units. Read SEC document |
| July 21, 2022 Filed Jul 22, 2022 20:07 UTC | agilon health, inc. AGL · Entity 4698 | Exercise / conversionCommon Stock | 49,676 | $1.00 | $49,676.00 |
DisclosureSEC source: 0001209191-22-042987 · doc4.xml · nonDerivative · entry 3 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,132 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · balance_after: Includes restricted stock units. Read SEC document |
| July 20, 2022 Filed Jul 22, 2022 20:07 UTC | agilon health, inc. AGL · Entity 4698 | SaleCommon Stock | 4,558 | $26.68 | $121,614.28 |
DisclosureSEC source: 0001209191-22-042987 · doc4.xml · nonDerivative · entry 2 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,456 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $26.63 to $26.84, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F3 · balance_after: Includes restricted stock units. Read SEC document |
| July 20, 2022 Filed Jul 22, 2022 20:07 UTC | agilon health, inc. AGL · Entity 4698 | SaleCommon Stock | 45,442 | $26.35 | $1,197,464.86 |
DisclosureSEC source: 0001209191-22-042987 · doc4.xml · nonDerivative · entry 1 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,014 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $25.63 to $26.62, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F3 · balance_after: Includes restricted stock units. Read SEC document |
| April 14, 2022 Filed Apr 20, 2022 20:58 UTC | agilon health, inc. AGL · Entity 4698 | GrantOptions (Rights to Buy) · Derivative | 44,580 | $0.00 Strike: $23.07 | $0.00 |
DisclosureSEC source: 0001209191-22-025020 · doc4.xml · derivative · entry 2 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,580 Underlying: Common Stock · 44,580 shares Expires 2032-04-14 F3 · derivative.exercise_date: Options that vest in four equal installments on each anniversary of April 14, 2022, subject to continued employment. F3 · derivative.expiration_date: Options that vest in four equal installments on each anniversary of April 14, 2022, subject to continued employment. Read SEC document |
| April 14, 2022 Filed Apr 20, 2022 20:58 UTC | agilon health, inc. AGL · Entity 4698 | GrantCommon Stock | 13,546 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-025020 · doc4.xml · nonDerivative · entry 1 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,456 F1 · shares: Restricted stock units that vest in four equal installments on each anniversary of April 14, 2022, subject to continued employment. F2 · balance_after: Includes restricted stock units. Read SEC document |
| April 14, 2022 Filed Sep 29, 2022 20:11 UTC Amendment | agilon health, inc. AGL · Entity 4698 | Tax withholdingCommon Stock | 1,507 | $23.07 | $34,766.49 |
DisclosureSEC source: 0001209191-22-051530 · doc4a.xml · nonDerivative · entry 1 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,625 F1 · kind: Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the restricted stock units and does not represent a sale. F2 · balance_after: Includes restricted stock units. Read SEC document |
| April 07, 2022 Filed Apr 11, 2022 20:06 UTC | agilon health, inc. AGL · Entity 4698 | SaleCommon Stock | 2,706 | $25.01 | $67,677.06 |
DisclosureSEC source: 0001209191-22-023973 · doc4.xml · nonDerivative · entry 1 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,910 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, which was adopted prior to September 7, 2021. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, which was adopted prior to September 7, 2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $25.00 to $25.04, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F3 · balance_after: Includes restricted stock units. Read SEC document |
| March 16, 2022 Filed Mar 18, 2022 20:16 UTC | agilon health, inc. AGL · Entity 4698 | Exercise / conversionOptions (Right to buy) · Derivative | 37,155 | $0.00 Strike: $3.00 | $0.00 |
DisclosureSEC source: 0001209191-22-020014 · doc4.xml · derivative · entry 3 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 201,851 Underlying: Common Stock · 37,155 shares Expires 2026-12-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options were granted on December 30, 2016 and vested on September 14, 2021. Read SEC document |
| March 16, 2022 Filed Mar 18, 2022 20:16 UTC | agilon health, inc. AGL · Entity 4698 | SaleCommon Stock | 37,155 | $20.20 | $750,531.00 |
DisclosureSEC source: 0001209191-22-020014 · doc4.xml · nonDerivative · entry 2 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,616 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $20.00 to $20.58, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| March 16, 2022 Filed Mar 18, 2022 20:16 UTC | agilon health, inc. AGL · Entity 4698 | Exercise / conversionCommon Stock | 37,155 | $3.00 | $111,465.00 |
DisclosureSEC source: 0001209191-22-020014 · doc4.xml · nonDerivative · entry 1 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,771 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| March 15, 2022 Filed Mar 16, 2022 21:39 UTC | agilon health, inc. AGL · Entity 4698 | Exercise / conversionOptions (Right to buy) · Derivative | 79,457 | $0.00 Strike: $3.00 | $0.00 |
DisclosureSEC source: 0001209191-22-019282 · doc4.xml · derivative · entry 8 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 239,006 Underlying: Common Stock · 79,457 shares Expires 2026-12-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: These options were granted on December 30, 2016 and vested on September 14, 2021. Read SEC document |
| March 15, 2022 Filed Mar 16, 2022 21:39 UTC | agilon health, inc. AGL · Entity 4698 | SaleCommon Stock | 79,457 | $19.25 | $1,529,547.25 |
DisclosureSEC source: 0001209191-22-019282 · doc4.xml · nonDerivative · entry 6 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,616 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $19.00 to $19.51, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| March 15, 2022 Filed Mar 16, 2022 21:39 UTC | agilon health, inc. AGL · Entity 4698 | Exercise / conversionCommon Stock | 79,457 | $3.00 | $238,371.00 |
DisclosureSEC source: 0001209191-22-019282 · doc4.xml · nonDerivative · entry 5 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,073 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| March 14, 2022 Filed Mar 16, 2022 21:39 UTC | agilon health, inc. AGL · Entity 4698 | Exercise / conversionOptions (Right to buy) · Derivative | 81,537 | $0.00 Strike: $3.00 | $0.00 |
DisclosureSEC source: 0001209191-22-019282 · doc4.xml · derivative · entry 7 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 318,463 Underlying: Common Stock · 81,537 shares Expires 2026-12-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: These options were granted on December 30, 2016 and vested on September 14, 2021. Read SEC document |
| March 14, 2022 Filed Mar 16, 2022 21:39 UTC | agilon health, inc. AGL · Entity 4698 | SaleCommon Stock | 30,867 | $21.25 | $655,923.75 |
DisclosureSEC source: 0001209191-22-019282 · doc4.xml · nonDerivative · entry 4 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,616 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $21.01 to $22.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| March 14, 2022 Filed Mar 16, 2022 21:39 UTC | agilon health, inc. AGL · Entity 4698 | SaleCommon Stock | 15,760 | $20.60 | $324,656.00 |
DisclosureSEC source: 0001209191-22-019282 · doc4.xml · nonDerivative · entry 3 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,483 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $20.01 to $21.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| March 14, 2022 Filed Mar 16, 2022 21:39 UTC | agilon health, inc. AGL · Entity 4698 | SaleCommon Stock | 34,910 | $19.64 | $685,632.40 |
DisclosureSEC source: 0001209191-22-019282 · doc4.xml · nonDerivative · entry 2 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,243 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $19.00 to $20.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| March 14, 2022 Filed Mar 16, 2022 21:39 UTC | agilon health, inc. AGL · Entity 4698 | Exercise / conversionCommon Stock | 81,537 | $3.00 | $244,611.00 |
DisclosureSEC source: 0001209191-22-019282 · doc4.xml · nonDerivative · entry 1 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 148,153 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| December 29, 2021 Filed Dec 30, 2021 21:46 UTC | agilon health, inc. AGL · Entity 4698 | SaleCommon Stock | 4,685 | $26.54 | $124,339.90 |
DisclosureSEC source: 0001209191-21-071605 · doc4.xml · nonDerivative · entry 2 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,616 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, which was adopted prior to September 7, 2021. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, which was adopted prior to September 7, 2021. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $26.18 to $26.84, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F3 · balance_after: Includes restricted stock units. Read SEC document |
| December 28, 2021 Filed Dec 30, 2021 21:46 UTC | agilon health, inc. AGL · Entity 4698 | SaleCommon Stock | 14,055 | $26.72 | $375,549.60 |
DisclosureSEC source: 0001209191-21-071605 · doc4.xml · nonDerivative · entry 1 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,301 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, which was adopted prior to September 7, 2021. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, which was adopted prior to September 7, 2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $26.45 to $27.09, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F3 · balance_after: Includes restricted stock units. Read SEC document |
| November 17, 2021 Filed Nov 18, 2021 21:02 UTC | agilon health, inc. AGL · Entity 4698 | SaleCommon Stock | 4,685 | $25.26 | $118,343.10 |
DisclosureSEC source: 0001209191-21-065428 · doc4.xml · nonDerivative · entry 2 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,356 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, which was adopted prior to September 7, 2021. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, which was adopted prior to September 7, 2021. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $25.04 to $25.40, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F3 · balance_after: Includes restricted stock units. Read SEC document |
| November 16, 2021 Filed Nov 18, 2021 21:02 UTC | agilon health, inc. AGL · Entity 4698 | SaleCommon Stock | 4,685 | $25.37 | $118,858.45 |
DisclosureSEC source: 0001209191-21-065428 · doc4.xml · nonDerivative · entry 1 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,041 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, which was adopted prior to September 7, 2021. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, which was adopted prior to September 7, 2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $25.11 to $25.50, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F3 · balance_after: Includes restricted stock units. Read SEC document |
| November 04, 2021 Filed Nov 8, 2021 21:49 UTC | agilon health, inc. AGL · Entity 4698 | SaleCommon Stock | 18,560 | $25.19 | $467,526.40 |
DisclosureSEC source: 0001209191-21-063399 · doc4.xml · nonDerivative · entry 1 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,726 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, which was adopted prior to September 7, 2021. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, which was adopted prior to September 7, 2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $25.00 to $25.70, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F3 · balance_after: Includes restricted stock units. Read SEC document |
| November 03, 2021 Filed Nov 4, 2021 20:48 UTC | agilon health, inc. AGL · Entity 4698 | SaleCommon Stock | 300 | $25.00 | $7,500.00 |
DisclosureSEC source: 0001209191-21-062941 · doc4.xml · nonDerivative · entry 1 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,286 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, which was adopted prior to September 7, 2021. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, which was adopted prior to September 7, 2021. F2 · balance_after: Includes restricted stock units. Read SEC document |
| September 14, 2021 Filed Sep 15, 2021 21:21 UTC | agilon health, inc. AGL · Entity 4698 | Exercise / conversionOptions (Rights to Buy) · Derivative | 73,018 | $0.00 Strike: $1.00 | $0.00 |
DisclosureSEC source: 0001209191-21-056206 · doc4.xml · derivative · entry 3 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 376,982 Underlying: Common Stock · 73,018 shares Expires 2026-12-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options were granted on December 30, 2016, and became fully vested as of January 12, 2021. Read SEC document |
| September 14, 2021 Filed Sep 15, 2021 21:21 UTC | agilon health, inc. AGL · Entity 4698 | SaleCommon Stock | 73,018 | $28.98 | $2,116,061.64 |
DisclosureSEC source: 0001209191-21-056206 · doc4.xml · nonDerivative · entry 2 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,586 F1 · balance_after: Includes restricted stock units. Read SEC document |
| September 14, 2021 Filed Sep 15, 2021 21:21 UTC | agilon health, inc. AGL · Entity 4698 | Exercise / conversionCommon Stock | 73,018 | $1.00 | $73,018.00 |
DisclosureSEC source: 0001209191-21-056206 · doc4.xml · nonDerivative · entry 1 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 186,604 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| April 14, 2021 Filed Apr 16, 2021 21:31 UTC | agilon health, inc. AGL · Entity 4698 | GrantOptions (Rights to Buy) · Derivative | 46,262 | $0.00 Strike: $23.00 | $0.00 |
DisclosureSEC source: 0001209191-21-027022 · doc4.xml · derivative · entry 2 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,262 Underlying: Common Stock · 46,262 shares Expires 2031-04-14 F2 · derivative.exercise_date: Options that vest in four equal installments on each anniversary of April 14, 2021, subject to continued employment. F2 · derivative.expiration_date: Options that vest in four equal installments on each anniversary of April 14, 2021, subject to continued employment. Read SEC document |
| April 14, 2021 Filed Apr 16, 2021 21:31 UTC | agilon health, inc. AGL · Entity 4698 | GrantCommon Stock | 13,586 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-027022 · doc4.xml · nonDerivative · entry 1 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,586 F1 · shares: Restricted stock units that vest in four equal installments on each anniversary of April 14, 2021, subject to continued employment. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.